Lamisil At (Terbinafine Hydrochloride)

Terbinafine inhibits the fungal enzyme squalene epoxidase, a key step in the biosynthesis of ergosterol, an essential component of fungal cell membranes. By blocking this pathway, the drug causes accumulation of toxic squalene and depletion of ergosterol, leading to fungal cell death and resolution of the infection.

The specific dosage and duration of Lamisil At are determined by the prescribing healthcare professional based on the type and severity of the infection, the area of skin involved, and patient factors. The prescriber will provide instructions on how much product to apply, how often, and for how many days.

Safety data for topical terbinafine during pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant, and only under the guidance of a qualified healthcare provider. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details, and assists with any necessary import documentation.

Lamisil At (terbinafine) belongs to the allylamine class, which acts by inhibiting squalene epoxidase, whereas azole antifungals block lanosterol 14α‑demethylase. Allylamines often achieve faster fungal clearance and are effective against dermatophytes, while azoles have a broader spectrum but may require longer treatment. Choice depends on infection type, patient tolerance, and physician preference.

Lamisil At should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, direct sunlight, and excessive heat. Do not freeze the product, and keep it out of reach of children.

The medication is applied topically to the affected skin area. Clean and dry the skin, then spread a thin layer of the cream or gel over the lesion and a small margin of surrounding healthy skin, usually once or twice daily as directed by the prescriber. Wash hands after application unless treating the hands.

Although rare, serious adverse reactions can occur, including severe allergic responses such as angioedema, widespread skin blistering, or systemic effects like liver enzyme elevation. If any signs of swelling, difficulty breathing, extensive rash, or jaundice develop, discontinue use immediately and seek medical attention.

Individuals with a known hypersensitivity to terbinafine or any component of the formulation should avoid using Lamisil At. It is also contraindicated on broken skin, mucous membranes, or extensive body surface areas without medical supervision. Patients with severe liver disease or those taking interacting systemic medications should consult a healthcare professional before use.